Linkage Projects - Grant ID: LP0883403

Funding Activity

Website
http://dataportal.arc.gov.au/NCGP/Web/Grant/Grant/LP0883403

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Development of chaperonin 10-based second generation biopharmaceuticals for treatment of inflammatory diseases. Diseases caused by malfunctioning of the body's immune system (inflammatory diseases) such as rheumatoid arthritis, psoriasis and Crohn's disease cause illness in all cultures and societies, and impose financial strain on health care providers. Current treatment relies on biopharmaceuticals that block inflammatory mediators in the body or with pharmaceuticals such as anti-inflammatory drugs; both these treatments may have serious side effects. Cpn10 suppresses the body's inflammatory response while maintaining immune function to combat infections. The project seeks to develop new, safe and effective biopharmaceuticals based on Cpn10 for the treatment of a variety of chronic inflammatory diseases and autoimmune disorders.

Funded Activity Details

Start Date: 29-03-2010

End Date: 28-03-2013

Funding Scheme: Linkage Projects

Funding Amount: $270,000.00

Funder: Australian Research Council

Research Topics

ANZSRC Field of Research (FoR)

Autoimmunity | Medical Biochemistry: Proteins And Peptides | Immunology | Immunology Not Elsewhere Classified

ANZSRC Socio-Economic Objective (SEO)

Treatments (e.g. chemicals, antibiotics) |

Other Keywords

Autoimmunity | Immunology | Immunology Not Elsewhere Classified | Medical Biochemistry: Proteins And Peptides | Treatments (e.g. chemicals, antibiotics)

Related Links